Corcept Therapeutics | CORT - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
J&J USD 84.97B 3.78B 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Merck USD 41.93B 3.94B 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06